RU2001133273A - Topical intraocular pressure lowering compositions - Google Patents
Topical intraocular pressure lowering compositionsInfo
- Publication number
- RU2001133273A RU2001133273A RU2001133273/14A RU2001133273A RU2001133273A RU 2001133273 A RU2001133273 A RU 2001133273A RU 2001133273/14 A RU2001133273/14 A RU 2001133273/14A RU 2001133273 A RU2001133273 A RU 2001133273A RU 2001133273 A RU2001133273 A RU 2001133273A
- Authority
- RU
- Russia
- Prior art keywords
- intraocular pressure
- angiotensin
- composition according
- antagonist
- compound
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 12
- 230000004410 intraocular pressure Effects 0.000 title claims 9
- 230000000699 topical Effects 0.000 title claims 3
- 239000002333 angiotensin II receptor antagonist Substances 0.000 claims 7
- 150000001875 compounds Chemical group 0.000 claims 6
- KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 4
- 239000004327 boric acid Substances 0.000 claims 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 4
- 230000002335 preservative Effects 0.000 claims 4
- 239000003755 preservative agent Substances 0.000 claims 4
- 208000010412 Glaucoma Diseases 0.000 claims 3
- -1 1H-tetrazol-5-yl Chemical group 0.000 claims 2
- KGMXGKIPZPNWST-UHFFFAOYSA-N 3-methylbenzimidazole-4-carboxylic acid Chemical compound C1=CC(C(O)=O)=C2N(C)C=NC2=C1 KGMXGKIPZPNWST-UHFFFAOYSA-N 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 1
- VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 claims 1
- VABRMEXIXWZVKZ-UHFFFAOYSA-N CCCCC(N(C)C(C)C(C)C)=O Chemical compound CCCCC(N(C)C(C)C(C)C)=O VABRMEXIXWZVKZ-UHFFFAOYSA-N 0.000 description 1
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11/164945 | 1999-06-11 | ||
JP16494599 | 1999-06-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001133273A true RU2001133273A (en) | 2003-08-10 |
RU2227740C2 RU2227740C2 (en) | 2004-04-27 |
Family
ID=15802847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001133273/15A RU2227740C2 (en) | 1999-06-11 | 2000-06-09 | Intraocular pressure-reducing composition for topical application |
Country Status (24)
Country | Link |
---|---|
US (1) | US6777436B2 (en) |
EP (1) | EP1186302B1 (en) |
KR (1) | KR100611543B1 (en) |
CN (1) | CN1198650C (en) |
AT (1) | ATE295721T1 (en) |
AU (1) | AU759513B2 (en) |
BR (1) | BR0011477A (en) |
CA (1) | CA2376780C (en) |
CZ (1) | CZ300553B6 (en) |
DE (1) | DE60020230T2 (en) |
ES (1) | ES2242619T3 (en) |
HK (1) | HK1042050A1 (en) |
HU (1) | HUP0201466A3 (en) |
IL (2) | IL146917A0 (en) |
MX (1) | MXPA01012752A (en) |
NO (1) | NO328211B1 (en) |
NZ (1) | NZ516033A (en) |
PL (1) | PL200009B1 (en) |
PT (1) | PT1186302E (en) |
RU (1) | RU2227740C2 (en) |
TR (1) | TR200103603T2 (en) |
TW (1) | TWI245639B (en) |
WO (1) | WO2000076543A1 (en) |
ZA (1) | ZA200109943B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4000505B2 (en) * | 1999-12-01 | 2007-10-31 | 第一三共株式会社 | Concomitant medications for treating glaucoma |
TW200304812A (en) * | 2002-03-08 | 2003-10-16 | Sankyo Co | An eye drop containing a tetrazole derivative |
US20050119299A1 (en) * | 2002-03-08 | 2005-06-02 | Sankyo Company, Limited | Ophthalmic solutions containing tetrazole derivatives |
ES2379580T3 (en) * | 2005-04-21 | 2012-04-27 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for keratoconjunctival disorder |
EP2529723B1 (en) | 2007-11-30 | 2016-05-11 | Toltec Pharmaceuticals, Llc | Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
WO1995021609A1 (en) * | 1994-02-08 | 1995-08-17 | Ciba-Geigy Ag | Treatment of normotensive glaucoma with angiotensin ii antagonists |
EP1110551B1 (en) * | 1994-03-16 | 2004-05-12 | Sankyo Company Limited | Ocular tension lowering agent |
JPH07324034A (en) * | 1994-05-30 | 1995-12-12 | Toa Yakuhin Kk | Eye drop containing ketotifen fumarate |
-
2000
- 2000-06-09 CA CA002376780A patent/CA2376780C/en not_active Expired - Fee Related
- 2000-06-09 ES ES00935630T patent/ES2242619T3/en not_active Expired - Lifetime
- 2000-06-09 EP EP00935630A patent/EP1186302B1/en not_active Expired - Lifetime
- 2000-06-09 TR TR2001/03603T patent/TR200103603T2/en unknown
- 2000-06-09 CN CNB008113513A patent/CN1198650C/en not_active Expired - Fee Related
- 2000-06-09 RU RU2001133273/15A patent/RU2227740C2/en not_active IP Right Cessation
- 2000-06-09 AT AT00935630T patent/ATE295721T1/en not_active IP Right Cessation
- 2000-06-09 WO PCT/JP2000/003779 patent/WO2000076543A1/en not_active Application Discontinuation
- 2000-06-09 NZ NZ516033A patent/NZ516033A/en not_active IP Right Cessation
- 2000-06-09 IL IL14691700A patent/IL146917A0/en active IP Right Grant
- 2000-06-09 KR KR1020017015901A patent/KR100611543B1/en not_active IP Right Cessation
- 2000-06-09 MX MXPA01012752A patent/MXPA01012752A/en active IP Right Grant
- 2000-06-09 CZ CZ20014415A patent/CZ300553B6/en not_active IP Right Cessation
- 2000-06-09 PL PL352161A patent/PL200009B1/en not_active IP Right Cessation
- 2000-06-09 PT PT00935630T patent/PT1186302E/en unknown
- 2000-06-09 HU HU0201466A patent/HUP0201466A3/en unknown
- 2000-06-09 BR BR0011477-4A patent/BR0011477A/en not_active Application Discontinuation
- 2000-06-09 TW TW089111297A patent/TWI245639B/en not_active IP Right Cessation
- 2000-06-09 DE DE60020230T patent/DE60020230T2/en not_active Expired - Lifetime
- 2000-06-09 AU AU51086/00A patent/AU759513B2/en not_active Ceased
-
2001
- 2001-12-03 ZA ZA200109943A patent/ZA200109943B/en unknown
- 2001-12-04 IL IL146917A patent/IL146917A/en not_active IP Right Cessation
- 2001-12-10 NO NO20016023A patent/NO328211B1/en not_active IP Right Cessation
- 2001-12-10 US US10/016,535 patent/US6777436B2/en not_active Expired - Fee Related
-
2002
- 2002-05-23 HK HK02103878A patent/HK1042050A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6451812B1 (en) | Farnesyl protein transferase inhibitors for treating arthropathies | |
JP2001517639A (en) | Use of a combination comprising a non-sedating antihistamine and an α-adrenergic agonist for the topical treatment of rhinitis / conjunctivitis and cold, cold-like and / or epidemic cold symptoms | |
JP2001526218A5 (en) | ||
JP2003509349A5 (en) | ||
EP1951240A2 (en) | Pharmaceutical compositions comprising buprenorphine | |
CA2013167A1 (en) | Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension | |
RU2009114166A (en) | SOLID MEDICINAL FORM OF OLMESARTAN MEDOXOMIL AND AMLODIPINE | |
US20130023536A1 (en) | Fixed dose combination of bimatoprost and brimonidine | |
JPH11228410A (en) | Chronic renal insufficiency therapeutic agent comprising imidazole angiotensin-ii receptor antagonist | |
JPH0696521B2 (en) | Ocular hypotensive agent for topical ocular administration | |
CA2103276A1 (en) | Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers | |
WO1991015206A1 (en) | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists | |
RU2001133273A (en) | Topical intraocular pressure lowering compositions | |
RU2227740C2 (en) | Intraocular pressure-reducing composition for topical application | |
ES2233362T3 (en) | AGENTS TO PREVENT / TREAT / INHIBIT THE ADVANCE OF SIMPLE RETINOPATHY OR PREPROLIFERATIVE RETINOPATHY. | |
AU2002350832B2 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
JP2004517808A5 (en) | ||
US5639773A (en) | Ocular hypotensive agent | |
US20040106582A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
UY26459A1 (en) | 3,4-DIHIDROQUINAZOLINES 5,6-DISSTITUTED | |
JPH0532635A (en) | Application of histamine derivative to therapy, a new histamine derivative and use of this derivative as medicine | |
KR930006009A (en) | 4- [4- [4- (4-hydroxyphenyl) -1-piperazinyl] phenyl] -5-methyl-3H-1,2,4-triazol-3-one derivative | |
US20070281947A1 (en) | Diarylmethylpiperazines As Prophylactic Or Therapeutic Agents For Viral Myocarditis | |
JPS60115520A (en) | Peripherally selective dopamine antagonist for treatment of ophthalmic hypertension | |
US5189051A (en) | Treatment of glaucoma and ocular hypertension with pyrrole angiotensin-II receptor antagonists |